Crossmark

212Pb in targeted radionuclide therapy: a review

Crossref DOI link: https://doi.org/10.1186/s41181-025-00362-7

Published Online: 2025-07-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Scaffidi-Muta, Jarred Michael https://orcid.org/0000-0003-0595-8966
Abell, Andrew David
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-01
More Information

Article History

Received: 27 March 2025

Accepted: 10 June 2025

First Online: 1 July 2025

Declarations

:

: Not applicable.

: Not applicable.

: JS is an employee of AdvanCell.